• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆汁酸介导的肝脏甘油三酯控制。

Bile acid-mediated control of liver triglycerides.

机构信息

Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Hans Popper Laboratory of Molecular Hepatology, Medical University of Vienna, Vienna, Austria.

出版信息

Semin Liver Dis. 2013 Nov;33(4):330-42. doi: 10.1055/s-0033-1358520. Epub 2013 Nov 12.

DOI:10.1055/s-0033-1358520
PMID:24222091
Abstract

Bile acids (BAs) are steroidal molecules generated in the liver by cholesterol oxidation. Beside their well-established role in lipid absorption and cholesterol homeostasis, they function as signaling molecules and activate dedicated BA receptors such as the farnesoid X receptor (FXR) and the G-protein coupled receptor TGR5. Through activation of downstream signaling pathways of these key receptors, BAs regulate not only their own synthesis and enterohepatic circulation, but also impact on hepatic lipid, glucose, and energy homeostasis. Therefore, BA-regulated signaling pathways have emerged as attractive targets for understanding the regulation of hepatic triglyceride metabolism in health and disease and treating fatty liver disease and associated metabolic disorders.

摘要

胆汁酸(BAs)是胆固醇氧化在肝脏中产生的甾体分子。除了在脂质吸收和胆固醇稳态中发挥的重要作用外,它们还作为信号分子发挥作用,并激活特定的 BA 受体,如法尼醇 X 受体(FXR)和 G 蛋白偶联受体 TGR5。通过这些关键受体下游信号通路的激活,BAs 不仅调节自身的合成和肠肝循环,还影响肝脏脂质、葡萄糖和能量稳态。因此,BA 调节的信号通路已成为理解健康和疾病中肝脏甘油三酯代谢调节以及治疗脂肪肝疾病和相关代谢紊乱的有吸引力的靶点。

相似文献

1
Bile acid-mediated control of liver triglycerides.胆汁酸介导的肝脏甘油三酯控制。
Semin Liver Dis. 2013 Nov;33(4):330-42. doi: 10.1055/s-0033-1358520. Epub 2013 Nov 12.
2
Bile acids as regulators of hepatic lipid and glucose metabolism.胆汁酸作为肝脏脂质和糖代谢的调节剂。
Dig Dis. 2010;28(1):220-4. doi: 10.1159/000282091. Epub 2010 May 7.
3
Bile acid receptors in non-alcoholic fatty liver disease.非酒精性脂肪性肝病中的胆汁酸受体。
Biochem Pharmacol. 2013 Dec 1;86(11):1517-24. doi: 10.1016/j.bcp.2013.08.015. Epub 2013 Aug 26.
4
Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy.胆汁酸受体 FXR 和 TGR5 在脂肪性肝病及其治疗中的作用。
Am J Physiol Gastrointest Liver Physiol. 2020 Mar 1;318(3):G554-G573. doi: 10.1152/ajpgi.00223.2019. Epub 2020 Jan 27.
5
Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet-fed mice.抑制回肠胆汁酸摄取可预防高脂饮食喂养小鼠的非酒精性脂肪性肝病。
Sci Transl Med. 2016 Sep 21;8(357):357ra122. doi: 10.1126/scitranslmed.aaf4823.
6
Bile acids and insulin resistance: implications for treating nonalcoholic fatty liver disease.胆汁酸与胰岛素抵抗:对非酒精性脂肪性肝病治疗的启示
J Dig Dis. 2009 May;10(2):85-90. doi: 10.1111/j.1751-2980.2009.00369.x.
7
Effects of therapeutically approved individual bile acids on the development of metabolic dysfunction-associated steatohepatitis a low bile acid mouse model.治疗批准的个体胆汁酸对代谢功能障碍相关脂肪性肝炎 a 低胆汁酸小鼠模型发展的影响。
Toxicol Sci. 2024 Dec 1;202(2):179-195. doi: 10.1093/toxsci/kfae110.
8
G-protein-coupled bile acid receptor plays a key role in bile acid metabolism and fasting-induced hepatic steatosis in mice.G蛋白偶联胆汁酸受体在小鼠胆汁酸代谢和禁食诱导的肝脂肪变性中起关键作用。
Hepatology. 2017 Mar;65(3):813-827. doi: 10.1002/hep.28707. Epub 2016 Jul 30.
9
Hepatic Bile Acid Reuptake in the Rat Depends on Bile Acid Conjugation but Not on Agonistic Properties towards FXR and TGR5.在大鼠中,肝脏胆汁酸再摄取依赖于胆汁酸的结合,但不依赖于 FXR 和 TGR5 的激动特性。
Molecules. 2020 May 20;25(10):2371. doi: 10.3390/molecules25102371.
10
Policosanol alleviates hepatic lipid accumulation by regulating bile acids metabolism in C57BL6/mice through AMPK-FXR-TGR5 cross-talk.聚多卡醇通过AMPK-FXR-TGR5相互作用调节C57BL6小鼠胆汁酸代谢,从而减轻肝脏脂质积累。
J Food Sci. 2021 Dec;86(12):5466-5478. doi: 10.1111/1750-3841.15951. Epub 2021 Nov 3.

引用本文的文献

1
Therapeutic Role of Polyphenol Extract from Ehrhart on Non-Alcoholic Fatty Liver.埃氏草多酚提取物对非酒精性脂肪肝的治疗作用
Plants (Basel). 2024 Jan 18;13(2):288. doi: 10.3390/plants13020288.
2
Interorgan communication with the liver: novel mechanisms and therapeutic targets.器官间与肝脏的通讯:新机制和治疗靶点。
Front Immunol. 2023 Dec 12;14:1314123. doi: 10.3389/fimmu.2023.1314123. eCollection 2023.
3
Integrated bioinformatics analysis reveals potential mechanisms associated with intestinal flora intervention in nonalcoholic fatty liver disease.
整合生物信息学分析揭示了肠道菌群干预非酒精性脂肪性肝病的潜在机制。
Medicine (Baltimore). 2022 Sep 9;101(36):e30184. doi: 10.1097/MD.0000000000030184.
4
Secondary Bile Acids and Tumorigenesis in Colorectal Cancer.继发性胆汁酸与结直肠癌的肿瘤发生
Front Oncol. 2022 Apr 28;12:813745. doi: 10.3389/fonc.2022.813745. eCollection 2022.
5
A review on the effect of gut microbiota on metabolic diseases.肠道微生物群对代谢性疾病影响的综述。
Arch Microbiol. 2022 Feb 23;204(3):192. doi: 10.1007/s00203-022-02802-3.
6
Associations Between GGT/HDL and MAFLD: A Cross-Sectional Study.γ-谷氨酰转肽酶与高密度脂蛋白比值和代谢功能障碍相关脂肪性肝病的关联:一项横断面研究。
Diabetes Metab Syndr Obes. 2022 Feb 9;15:383-394. doi: 10.2147/DMSO.S342505. eCollection 2022.
7
Hyperoside attenuates non-alcoholic fatty liver disease in rats via cholesterol metabolism and bile acid metabolism.金丝桃苷通过胆固醇代谢和胆汁酸代谢减轻大鼠非酒精性脂肪肝病。
J Adv Res. 2021 Jun 8;34:109-122. doi: 10.1016/j.jare.2021.06.001. eCollection 2021 Dec.
8
A high-fat diet and high-fat and high-cholesterol diet may affect glucose and lipid metabolism differentially through gut microbiota in mice.高脂肪饮食和高脂肪高胆固醇饮食可能通过肠道微生物群在小鼠中对葡萄糖和脂质代谢产生不同的影响。
Exp Anim. 2021 Feb 6;70(1):73-83. doi: 10.1538/expanim.20-0094. Epub 2020 Oct 1.
9
Increased circulating total bile acid levels were associated with organ failure in patients with acute pancreatitis.急性胰腺炎患者循环总胆汁酸水平升高与器官衰竭相关。
BMC Gastroenterol. 2020 Jul 13;20(1):222. doi: 10.1186/s12876-020-01243-w.
10
Why Bile Acids Are So Important in Non-Alcoholic Fatty Liver Disease (NAFLD) Progression.为什么胆汁酸在非酒精性脂肪性肝病(NAFLD)进展中如此重要。
Cells. 2019 Oct 30;8(11):1358. doi: 10.3390/cells8111358.